DaVita
DVA
#1864
Rank
HK$91.56 B
Marketcap
HK$1,427
Share price
-1.03%
Change (1 day)
40.83%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): HK$85.94

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$86.30. In 2025 the company made an earnings per share (EPS) of HK$79.39 a decrease over its 2024 EPS that were of HK$86.53.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$85.948.25%
2025HK$79.39-8.25%
2024HK$86.5344.94%
2023HK$59.7027.26%
2022HK$46.91-35.56%
2021HK$72.8044.1%
2020HK$50.5219.7%
2019HK$42.21540.48%
2018HK$6.59-76.07%
2017HK$27.54-19.31%
2016HK$34.13242.52%
2015HK$9.96-62.87%
2014HK$26.8313.43%
2013HK$23.658.45%
2012HK$21.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$190.72 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$89.12 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$152.12 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$16.23-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA